Inhibition of Phospholipase C-γ1 Activation Blocks Glioma Cell Motility and Invasion of Fetal Rat Brain Aggregates
- 1 March 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 44 (3) , 568-577
- https://doi.org/10.1097/00006123-199903000-00073
Abstract
Phospholipase C (PLC)-y is a cytosolic enzyme activated by several growth factor (GF) receptors (epidermal GF receptor [EGFR], platelet-derived GF receptor, and insulin-like GF 1 receptor), and its activation is associated with increased cell motility (but not cell proliferation) in nonglioma cell lines. Because up-regulated activation of EGFR has been consistently linked to poor patient survival in patients with glioblastoma multiforme (GBM) and because inhibition of EGFR activation by tyrosine kinase inhibitors prevents glioma infiltration in vitro, we hypothesized that inhibition of PLC-y activation would inhibit glioma cell invasiveness. Our experimental model assesses tumor spheroid invasion of fetal rat brain spheroids by confocal microscopy. We treated U87 GBM spheroids, and those derived from a single patient, with the PLC inhibitor U73122. We also transfected rat C6 glioma cells with the PLCz complementary deoxyribonucleic acid coding for a dominant negative PLC-γ1 src-homology-2/src-homology-3 peptide fragment, which blocks binding and activation of PLC-γ1 by GF receptors. Two clones (C6F and C6E) were grown into spheroids and were tested for invasiveness in the spheroid model and for responsiveness to GFs in a standard in vitro motility assay. The infiltration rate of the patient GBM cell line overexpressing wild-type EGFR was reduced by 2 μmol/L U73122 from a slope (percent invasion/h) of 0.74 ± 0.08 (with the inactive congener U73343) to 0.04 ± 0.053 (P = 8 × 10−7 by two-tailed t test, 92% reduction); the integral rate, another measure of invasion, was reduced from 49.7 ± 13 percent-hours per hour to 13.6 ± 12 (P = 0.002, 72% reduction). The U87 spheroid invasion rate was reduced by 0.5 μmol/L U73122 from 46.7 ± 8.5 percent-hours per hour to 11.2 ± 4.6 (P = 3×10−5); the slope decreased from 1.7 ± 0.41 percent per hour to 0.35 ± 0.14 (P = 0.0001). The C6F and C6E clones demonstrated attachment to and “surrounding” of the fetal rat brain aggregate but no true invasion by confocal or light c microscopy. PLCz blocked the motility response to epidermal GF, platelet-derived GF, and insulin-like GF. There was a significant decrease in PLC-γ1-associated tyrosine phosphorylation.Keywords
This publication has 49 references indexed in Scilit:
- A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.The Journal of cell biology, 1996
- Mutant IGF-I Receptors as Dominant Negatives for Growth and TransformationBiochemical and Biophysical Research Communications, 1995
- Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: Detection with reverse transcription-polymerase chain reactionCellular and Molecular Neurobiology, 1995
- Glioblastoma Cells Do Not Intravasate into Blood VesselsNeurosurgery, 1995
- Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.The Journal of cell biology, 1994
- Stimulation or inhibition of A431 cell growth by EGF is directly correlated with receptor tyrosine kinase concentration but not with PLCγ activityLife Sciences, 1993
- Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathwaysJournal of Neurosurgery, 1990
- Possible role of phospholipase C in the regulation of cell division in normal and neoplastic cellsMedical Hypotheses, 1989
- Enhancement of Growth of Primary Metastatic Fresh Human Tumors of the Nervous System by Epidermal Growth Factor in Serum-free Short Term CultureNeurosurgery, 1988
- Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cellsJournal of Neuroscience Research, 1982